Skip to main content
Intended for healthcare professionals

Bladder Cancer is an international multidisciplinary journal aiming to facilitate progress in understanding the epidemiology, etiology, molecular genetics, pathogenesis, pathobiology and pharmacology of tumors of the bladder and upper urinary tract with the objective of improving diagnosis, treatment and survivorship in patients. View full journal description

Browse by

Articles most recently published online for this journal.
Open Access
Research article
First published  

Treatment patterns and outcomes with second-line therapies in patients with advanced urothelial carcinoma previously treated with first-line enfortumab vedotin with pembrolizumab

  • Georges Gebrael
  • Yeonjung Jo
  • Zeynep Irem Ozay
  • Varun Nandakumar
  • Antonio Cigliola
  • Valentina Tateo
  • Edwin Lin
  • Micah Ostrowski
  • Nicolas Sayegh
  • Ethan Murdock
  • Vinay Mathew Thomas
  • Sumati Gupta
  • Neeraj Agarwal
  • Umang Swami
Open Access
Review article
First published  

Adjuvant immunotherapy for muscle-invasive urothelial carcinoma: Considerations for targeting patients

  • Sarafina Urenna Otis
  • Aruni Ghose
  • Giuseppe Luigi Banna
  • Akash Maniam
Open Access
Research article
First published  

Analysis of sarcopenia indicators on survival prediction undergoing radical cystectomy

  • Enes Malik Akdaş
  • Kerem Teke
  • Engin Telli
  • Efe Bosnalı
  • Serdar Baykal
  • Önder Kara
  • Hasan Yılmaz
  • Özdal Dillioğlugil
Open Access
Research article
First published  

Circulating tumor DNA–guided adjuvant immunotherapy in muscle-invasive bladder cancer

  • Kamil Malshy
  • Edward M. Messing
View latest issues
Most read articles in this journal in the last 6 months.
Open Access
Research article
First published  

In the World of Bladder Tumors: Size Does Matter

  • Justin Loloi
  • Jordan L. Allen
  • Amber Schilling
  • Christopher Hollenbeak
  • Suzanne B. Merrill
  • Matthew G. Kaag
  • Jay D. Raman
Open Access
Review article
First published  

Emerging bladder-sparing treatments for high risk non-muscle invasive bladder cancer

  • Clarissa M Gurbani
  • Yew-Lam Chong
  • Zhen Wei Choo
  • David Chia
  • Puey Ling Chia
  • Elise Vong
  • Sharon EK Yeo
  • Zhenbang Liu
  • Thiruchelvam Jegathesan
  • Jia-Lun Kwok
  • Soon Hock Koh
  • Daniel ZP Yong
  • Jeffrey J Leow
Open Access
Review article
First published  

Small cell carcinoma of the bladder: Review of pathogenesis, presentation, and management

  • Nicholas I Simon
  • Andre R Kydd
  • Dilara Akbulut
  • David Takeda
  • Jaydira Del Rivero
  • Maria Merino
  • Bernadette Redd
  • Liza Lindenberg
  • Esther Mena
  • Elias Chandran
  • Sandeep Gurram
  • Salah Boudjadi
  • Scot Niglio
  • Parth Sharma
  • Anish Thomas
  • Andrea B Apolo
View all
Most cited articles published in this journal in the last 3 years. These statistics are updated weekly using data sourced exclusively from CrossRef.
Open Access
Review article
First published  

Single-cell RNA sequencing and spatial transcriptome analysis in bladder cancer: Current status and future perspectives

  • Kentaro Yoshihara
  • Kagenori Ito
  • Takahiro Kimura
  • Yusuke Yamamoto
  • Fumihiko Urabe
Open Access
Review article
First published  

Noninvasive Tests for Bladder Cancer Detection and Surveillance: A Systematic Review of Commercially Available Assays

  • John R. Heard
  • Anirban P. Mitra
Open Access
Review article
First published  

Comparison of Robotic vs Open Cystectomy: A Systematic Review

  • Niranjan J. Sathianathen
  • Henry Y.C. Pan
  • Marc Furrer
  • Benjamin Thomas
  • Philip Dundee
  • Niall Corcoran
  • Christopher J. Weight
  • Badrinath Konety
  • Rajesh Nair
  • Nathan Lawrentschuk
Open Access
Review article
First published  

NK Cell-Targeted Immunotherapies in Bladder Cancer: Beyond Checkpoint Inhibitors

  • Yuanshuo A. Wang
  • Daniel Ranti
  • Christine Bieber
  • Matthew Galsky
  • Nina Bhardwaj
  • John P. Sfakianos
  • Amir Horowitz
View all
Articles with the highest Altmetric score from the last 3 months, indicating influence and impact.
Challenging Cases
Clinical Trials
Paper Alert

You might be interested in

Publish with us

Authors will enjoy:

  • Rigorous peer review of your research
  • Prompt publishing
  • Multidisciplinary audience
  • High visibility for global exposure
Submit Now

Information for Authors, Editors, and Reviewers

Sage supports authors, editors, and reviewers throughout all steps of the publishing process. Explore our resources:

Sage discipline hubs

Explore the content from across our disciplines, including the latest journal articles, special issues, and related books and digital library content.
View More

Also from Sage